STOCK TITAN

Apyx Medical Corporation to Participate in Upcoming Investor Conferences in November

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Apyx Medical Corporation (NASDAQ:APYX) announced its participation in upcoming investor conferences, including the Stephens Annual Investment Conference, Craig-Hallum 14th Annual Alpha Select Conference, and Piper Sandler 35th Annual Healthcare Conference. Management will engage in fireside chats and 1x1 meetings, with audio webcasts available for replay on the company's investor relations website.
Positive
  • None.
Negative
  • None.

CLEARWATER, Fla.--(BUSINESS WIRE)-- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the following upcoming investor conferences:

The Stephens Annual Investment Conference at the Nashville Grand Hyatt in Nashville, TN

  • Management will participate in a fireside chat on Tuesday, November 14 at 12:00 p.m. Eastern Time.

The Craig-Hallum 14th Annual Alpha Select Conference at the Sheraton NY Times Square Hotel in New York, NY

  • Management will participate in 1x1 meetings on Thursday, November 16. There will be no formal presentation.

The Piper Sandler 35th Annual Healthcare Conference at the Lotte New York Palace in New York, NY

  • Management will participate in a fireside chat on Wednesday, November 29 at 4:00 p.m. Eastern Time.

Audio webcasts of the fireside chat will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/. The webcasts will be achieved and available for replay following the conferences.

About Apyx Medical Corporation:

Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.

Investor Relations:



ICR Westwicke on behalf of Apyx Medical Corporation

Mike Piccinino, CFA

investor.relations@apyxmedical.com

Source: Apyx Medical Corporation

Apyx Medical Corporation is participating in the Stephens Annual Investment Conference, Craig-Hallum 14th Annual Alpha Select Conference, and Piper Sandler 35th Annual Healthcare Conference.

Management will engage in fireside chats and 1x1 meetings at the conferences.

The audio webcasts will be available for replay on the company's investor relations website at https://apyxmedical.com/investor_relations/.
Apyx Medical Corporation

NASDAQ:APYX

APYX Rankings

APYX Latest News

APYX Stock Data

48.50M
24.98M
17.92%
48.15%
2.04%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
CLEARWATER

About APYX

apyx medical corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. it operates in two segments, advanced energy and original equipment manufacturing (oem). the company develops j-plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. it markets and sells helium plasma technology under the renuvion brand name in the cosmetic surgery market and under the j-plasma brand name in the hospital surgical market. the company's renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the j-plasma system allows surgeons to operate in eliminating unintended tissue trauma. it also designs, develops, manufactures, and sells electrosurgical and oem generators and related accessories for medical device manufacturers. the company was formerly known as bovie medical corporation and changed